Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Obesity Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Obesity Therapeuticsmarket, defines the market attractiveness level of Anti-Obesity Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Obesity Therapeutics industry, describes the types of Anti-Obesity Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Obesity Therapeutics market and the development prospects and opportunities of Anti-Obesity Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Obesity Therapeutics market in Chapter 13.
By Player:
Rhythm Pharmaceuticals
Alizyme
BoehringerIngelheim GmbH
Norgine Pharmaceuticals Ltd
Pfizer
Takeda Pharmaceutical
FlaxoSithKline plc
Vivus
Novo Nordisk
Eisai Company
Bristol-Myers Squibb
Shionogi USA
Zafgen
By Type:
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
By End-User:
Peripherally Acting Anti-obesity Drugs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Obesity Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Obesity Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Obesity Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Obesity Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Obesity Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.2 United States Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.3 Europe Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.4 China Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.5 Japan Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.6 India Anti-Obesity Therapeutics Consumption (2017-2022)
-
7.7 South Korea Anti-Obesity Therapeutics Consumption (2017-2022)
8 Region and Country-wise Anti-Obesity Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Obesity Therapeutics Consumption Forecast (2022-2028)
9 Global Anti-Obesity Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Obesity Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Centrally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Peripherally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Obesity Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Peripherally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
10 Global Anti-Obesity Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Obesity Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Centrally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Peripherally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Obesity Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Peripherally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Obesity Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Obesity Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Obesity Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Obesity Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Obesity Therapeutics Market Competitive Analysis
-
14.1 Rhythm Pharmaceuticals
-
14.1.1 Rhythm Pharmaceuticals Company Details
-
14.1.2 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product and Service
-
14.2 Alizyme
-
14.2.1 Alizyme Company Details
-
14.2.2 Alizyme Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alizyme Anti-Obesity Therapeutics Product and Service
-
14.3 BoehringerIngelheim GmbH
-
14.3.1 BoehringerIngelheim GmbH Company Details
-
14.3.2 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product and Service
-
14.4 Norgine Pharmaceuticals Ltd
-
14.4.1 Norgine Pharmaceuticals Ltd Company Details
-
14.4.2 Norgine Pharmaceuticals Ltd Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Norgine Pharmaceuticals Ltd Anti-Obesity Therapeutics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Anti-Obesity Therapeutics Product and Service
-
14.6 Takeda Pharmaceutical
-
14.6.1 Takeda Pharmaceutical Company Details
-
14.6.2 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Product and Service
-
14.7 FlaxoSithKline plc
-
14.7.1 FlaxoSithKline plc Company Details
-
14.7.2 FlaxoSithKline plc Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 FlaxoSithKline plc Anti-Obesity Therapeutics Product and Service
-
14.8 Vivus
-
14.8.1 Vivus Company Details
-
14.8.2 Vivus Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vivus Anti-Obesity Therapeutics Product and Service
-
14.9 Novo Nordisk
-
14.9.1 Novo Nordisk Company Details
-
14.9.2 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novo Nordisk Anti-Obesity Therapeutics Product and Service
-
14.10 Eisai Company
-
14.10.1 Eisai Company Company Details
-
14.10.2 Eisai Company Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Eisai Company Anti-Obesity Therapeutics Product and Service
-
14.11 Bristol-Myers Squibb
-
14.11.1 Bristol-Myers Squibb Company Details
-
14.11.2 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Product and Service
-
14.12 Shionogi USA
-
14.12.1 Shionogi USA Company Details
-
14.12.2 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shionogi USA Anti-Obesity Therapeutics Product and Service
-
14.13 Zafgen
-
14.13.1 Zafgen Company Details
-
14.13.2 Zafgen Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Zafgen Anti-Obesity Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Obesity Therapeutics
-
Figure Anti-Obesity Therapeutics Picture
-
Table Global Anti-Obesity Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Obesity Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Obesity Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Obesity Therapeutics Consumption by Country (2017-2022)
-
Figure United States Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Obesity Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Obesity Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Obesity Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Centrally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Peripherally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Peripherally Acting Anti-obesity Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Centrally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripherally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripherally Acting Anti-obesity Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Obesity Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Obesity Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Rhythm Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product and Service
-
Table Alizyme (Foundation Year, Company Profile and etc.)
-
Table Alizyme Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alizyme Anti-Obesity Therapeutics Product and Service
-
Table BoehringerIngelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product and Service
-
Table Norgine Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Norgine Pharmaceuticals Ltd Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Norgine Pharmaceuticals Ltd Anti-Obesity Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-Obesity Therapeutics Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Product and Service
-
Table FlaxoSithKline plc (Foundation Year, Company Profile and etc.)
-
Table FlaxoSithKline plc Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table FlaxoSithKline plc Anti-Obesity Therapeutics Product and Service
-
Table Vivus (Foundation Year, Company Profile and etc.)
-
Table Vivus Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vivus Anti-Obesity Therapeutics Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Anti-Obesity Therapeutics Product and Service
-
Table Eisai Company (Foundation Year, Company Profile and etc.)
-
Table Eisai Company Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Company Anti-Obesity Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Product and Service
-
Table Shionogi USA (Foundation Year, Company Profile and etc.)
-
Table Shionogi USA Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shionogi USA Anti-Obesity Therapeutics Product and Service
-
Table Zafgen (Foundation Year, Company Profile and etc.)
-
Table Zafgen Anti-Obesity Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zafgen Anti-Obesity Therapeutics Product and Service
-
